Net revenues (Tables)

9 Months Ended

Sep. 26, 2021

Revenue from Contract with Customer [Abstract]

Schedule of Revenue by Major Customers by Reporting Segments

The following table disaggregates revenue by global product category for the three and nine months ended September 26, 2021 and September 27, 2020.

	Three Months Ended				Nine Months Ended
	September 26, 2021		September 27, 2020		September 26, 2021		September 27, 2020
Vascular access	$	175,476	$	160,052	$	507,188	$	475,252
Anesthesia	97,074		75,647		277,357		216,204
Interventional	104,304		93,187		312,559		275,704
Surgical	92,831		82,223		271,402		224,928
Interventional urology	83,107		81,773		248,714		196,114
OEM	64,083		49,399		178,528		168,618
Other (1)	83,376		86,020		251,901		269,157
Net revenues (2)	$	700,251	$	628,301	$	2,047,649	$	1,825,977

(1)Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products).

(2)The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments include net revenues from each of the non-OEM product categories listed above.